Immune responses regulated by cannabidiol

JM Nichols, BLF Kaplan - Cannabis and cannabinoid research, 2020‏ - liebertpub.com
Introduction: Cannabidiol (CBD) as Epidiolex®(GW Pharmaceuticals) was recently
approved by the US Food and Drug Administration (FDA) to treat rare forms of epilepsy in …

A review of hemp as food and nutritional supplement

P Cerino, C Buonerba, G Cannazza… - Cannabis and …, 2021‏ - liebertpub.com
The term “hemp” refers to Cannabis sativa cultivars grown for industrial purposes that are
characterized by lower levels of tetrahydrocannabinol (THC), the active principle …

Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study

N Frane, E Stapleton, C Iturriaga, M Ganz… - Journal of cannabis …, 2022‏ - Springer
Abstract Introduction An estimated 54 million Americans currently suffer from debilitating
arthritis. Patients who have exhausted conservative measures can be subject to chronic pain …

Cannabinoids, endocannabinoids and sleep

AJ Kesner, DM Lovinger - Frontiers in molecular neuroscience, 2020‏ - frontiersin.org
Sleep is a vital function of the nervous system that contributes to brain and bodily
homeostasis, energy levels, cognitive ability, and other key functions of a variety of …

[HTML][HTML] Medicinal cannabis—potential drug interactions

MA Alsherbiny, CG Li - Medicines, 2018‏ - mdpi.com
The endocannabinoids system (ECS) has garnered considerable interest as a potential
therapeutic target in various carcinomas and cancer-related conditions alongside …

Therapeutic efficacy of cannabidiol (CBD): a review of the evidence from clinical trials and human laboratory studies

DJ Sholler, L Schoene, TR Spindle - Current addiction reports, 2020‏ - Springer
Rigorous, controlled evidence for the therapeutic efficacy of CBD is lacking for many health
conditions. Possible concerns with the use of CBD as a therapeutic include the potential for …

Phytocannabinoids: Exploring pharmacological profiles and their impact on therapeutical use

NM Blebea, AI Pricopie, RA Vlad, G Hancu - International Journal of …, 2024‏ - mdpi.com
Phytocannabinoids, a diverse group of naturally occurring compounds extracted from the
Cannabis plant, have attracted interest due to their potential pharmacological effects and …

Emerging use of epidiolex (cannabidiol) in epilepsy

R Abu-Sawwa, B Scutt, Y Park - The Journal of Pediatric …, 2020‏ - meridian.allenpress.com
The first plant-derived, purified pharmaceutical-grade cannabidiol (CBD) medication,
Epidiolex, was approved in the United States by the FDA on June 25, 2018. Its approval for …

Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users

TR Spindle, EJ Cone, E Goffi, EM Weerts… - Drug and alcohol …, 2020‏ - Elsevier
Introduction The use and availability of oral and inhalable products containing cannabidiol
(CBD) as the principal constituent has increased with expanded cannabis/hemp …

CBD (cannabidiol) product attitudes, knowledge, and use among young adults

M Wheeler, JW Merten, BT Gordon… - Substance use & …, 2020‏ - Taylor & Francis
Abstract Background: Cannabidiol (CBD), a non-psychoactive component of cannabis is
marketed as a potential treatment for many conditions and widely available to purchase as a …